We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.65B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+22.9%
3 Year Est. Return
+58.88%
5 Year Est. Return
+87.69%
10 Year Est. Return
+260.41%
AUM
$1.48B
AUM Growth
+$79.9M
Cap. Flow
-$33M
Cap. Flow %
-2.22%
Top 10 Hldgs %
50.08%
Holding
108
New
3
Increased
15
Reduced
65
Closed
6

Top Buys

Rank Stock Value
1
RTO icon
Rentokil
RTO
+$3.24M
2
GPN icon
Global Payments
GPN
+$2.15M
3
IQV icon
IQVIA
IQV
+$1.33M
4
APD icon
Air Products & Chemicals
APD
+$1.07M
5
TMO icon
Thermo Fisher Scientific
TMO
+$989K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$9.12M
2
MSFT icon
Microsoft
MSFT
+$3.4M
3
AAPL icon
Apple
AAPL
+$2.51M
4
CAT icon
Caterpillar
CAT
+$2.39M
5
MRK icon
Merck
MRK
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 29.56%
2 Healthcare 22.24%
3 Consumer Staples 11.39%
4 Industrials 8.74%
5 Financials 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$130B
$18.2M 1.22%
51,013
-1,312
-3% -$441K
CVS icon
27
CVS Health
CVS
$122B
$16.7M 1.13%
209,579
-119,362
-36% -$9.12M
CSCO icon
28
Cisco
CSCO
$479B
$16.7M 1.12%
334,626
-5,192
-2% -$259K
ALC icon
29
Alcon
ALC
$35B
$14.7M 0.99%
177,195
+5,281
+3% +$424K
MDT icon
30
Medtronic
MDT
$112B
$14.4M 0.97%
165,262
-1,349
-0.8% -$115K
SO icon
31
Southern Company
SO
$107B
$13.8M 0.93%
192,302
-1,925
-1% -$133K
TMO icon
32
Thermo Fisher Scientific
TMO
$220B
$11.1M 0.75%
19,089
+1,763
+10% +$989K
GPN icon
33
Global Payments
GPN
$22.8B
$11M 0.74%
82,436
+16,262
+25% +$2.15M
APD icon
34
Air Products & Chemicals
APD
$67.6B
$10.6M 0.71%
43,884
+4,376
+11% +$1.07M
XOM icon
35
ExxonMobil
XOM
$634B
$9.5M 0.64%
81,745
-2,070
-2% -$217K
EXPD icon
36
Expeditors International
EXPD
$23.2B
$6.51M 0.44%
53,527
-13,409
-20% -$1.66M
AZPN
37
DELISTED
Aspen Technology Inc
AZPN
$6.27M 0.42%
29,415
+4,748
+19% +$936K
WDS icon
38
Woodside Energy
WDS
$42.6B
$5.14M 0.35%
257,449
+2,580
+1% +$52.2K
ABBV icon
39
AbbVie
ABBV
$435B
$5.09M 0.34%
27,940
-62
-0.2% -$10.7K
STT icon
40
State Street
STT
$50.7B
$4.94M 0.33%
63,837
-5,950
-9% -$441K
EMR icon
41
Emerson Electric
EMR
$88.3B
$4.77M 0.32%
42,087
-6,575
-14% -$675K
JPM icon
42
JPMorgan Chase
JPM
$950B
$4.75M 0.32%
23,734
+1
+0% +$180
GE icon
43
GE Aerospace
GE
$384B
$4.45M 0.3%
31,733
ABT icon
44
Abbott
ABT
$187B
$4.19M 0.28%
36,862
-534
-1% -$61.2K
NVS icon
45
Novartis
NVS
$297B
$4.19M 0.28%
43,296
-2,647
-6% -$271K
INTC icon
46
Intel
INTC
$513B
$4.08M 0.27%
92,419
-3,689
-4% -$164K
ECL icon
47
Ecolab
ECL
$79.9B
$3.86M 0.26%
16,729
-9,174
-35% -$1.95M
MKC icon
48
McCormick & Company Non-Voting
MKC
$14.2B
$3.73M 0.25%
48,572
-863
-2% -$58.6K
SHW icon
49
Sherwin-Williams
SHW
$89.8B
$3.64M 0.25%
10,528
-903
-8% -$288K
WAT icon
50
Waters Corp
WAT
$39.9B
$3.42M 0.23%
9,948
-314
-3% -$103K

Similar funds

Nichols & Pratt Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Nichols & Pratt Advisers held 108 positions worth $1.48B, up 5.7% from $1.41B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Nichols & Pratt Advisers's Q1 2024 filing shows 3 new, 15 increased, 65 reduced and 6 closed positions. Its largest new stake was Keysight: 3,987 shares worth $623K. The largest sale was CVS Health, an estimated $9.12M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q1 2024 buy was Keysight: 3,987 shares worth $623K.
  • Nichols & Pratt Advisers added most to Rentokil in Q1 2024, an estimated $3.24M increase.
  • Nichols & Pratt Advisers's biggest Q1 2024 reduction was CVS Health, cutting an estimated $9.12M.
  • Nichols & Pratt Advisers fully exited iShares Core S&P 500 ETF in Q1 2024, selling an estimated $299K.
  • Nichols & Pratt Advisers's ten largest holdings make up 50% of its $1.48B portfolio in Q1 2024.
  • Nichols & Pratt Advisers opened 3 new positions and closed 6 in Q1 2024.
  • Nichols & Pratt Advisers's portfolio value rose 5.7% quarter-over-quarter to $1.48B.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2024, filed 29 Apr 2024.